P

Palisade Bio
D

PALI

0.93580
USD
-0.03
(-3.03%)
مغلق
حجم التداول
9,500
الربح لكل سهم
-4
العائد الربحي
-
P/E
-0
حجم السوق
2,775,564
الأخبار المقالات

العنوان: Palisade Bio

القطاع: Healthcare
الصناعة: Biotechnology
Palisade Bio Inc is a clinical-stage biopharma company focused on identifying and developing therapeutics that protect the integrity of the intestinal barrier. Its portfolio consists of a PALI-2108 for the treatment of IBD, including UC and CD, and is researching PALI-1908.